HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est

Loading news article.

HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est | WAPE

HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est

Article summary

Related companies

Comments —